Prima Biomed shares halted pending announcement of oral vaccine for cervical cancer. [ + ]

Early-stage biotechnology companies were hardest hit by the GFC, but NemGenix has made it through by embracing every form of funding available. [ + ]

Prince Henry's Institute researchers pick up prestigious medals from UK Society of Endocrinology. [ + ]

Visualising the interactome isn't easy. But now Marc Wilkins and his team have developed a new tool, The Interactorium, that enables protein interactions to be visualised – all in stunning 3D. [ + ]

QRxPharma raises $21.6 m and Living Cell Technology offers share purchase plan. [ + ]

Katharina Gaus explores life’s humble container and finds the cell’s lipid coat is more complex than we expected. [ + ]

$1 million Ramaciotti foundation award to create world's first centre to study kinomics. [ + ]

Biota Holdings, ChemGenex, pSividia, Patrys, Blackmores [ + ]

University of Melbourne researchers collaborating with Patrys receive $300K grant for anti-cancer treatment. [ + ]

Researchers at the University of Newcastle and the Cooperative Research Centre (CRC) for Asthma and Airways have found a way to stop inflammation, the main cause of asthma and other chronic diseases, by blocking malfunctioning microRNA molecules.

Through its Super Science initiative, the federal government is recognising the importance of information technology as an innovation driver.

FDA grants ChemGenex Priority Review for New Drug Application for Omapro. [ + ]

Mesoblast (ASX:MSB) ups and downs after trial successes. [ + ]

With New Zealand government recently opening the door to xenotransplantation trials – it is time for the Australian government to reconsider its moratorium. [ + ]

Up to $5 million will be made available in the current round of the NSW Science Leveraging Fund program and expressions of interest are now welcome.